Mr. David Clarke, CEO
Neuren Pharmaceuticals

Dr. Sandra Webb,
Senior Vice-President of Licensing and Business Development
Phosphagenics Limited

Dr. Greg Collier, CEO and Managing Director,
ChemGenex Pharmaceuticals

Dr. Bruce M. Pratt, Vice President of Science Development,
GenzymeCorporation

William M. Wardell, MD PhD,
President,
Wardell Associates International, LLC

Dr. Hugo Stephenson, MD, President,
Strategic Research Services,
QuintilesTransnational Corp

Dr. Ed Mascioli, MDBusiness, Executive Partner,
MPM Capital

Dr. Campbell Murray, Director,
Novartis BioVenture Fund

Tom Salemi, Dow Jones & Co, Editor,
The Venture Capital Analyst: Health Care

Dr. Una Ryan, President and CEO,
AVANT Immunotherapeutics, Inc.

Michael Levy, Vice President, Alliance Management,
Bristol-Myers Squibb Company

Shreefal Mehta, Ph.D. MBA, Vice President,
Business and Corporate Development,
Cytopia

Dr. Joshua Funder, BSc (Hons), LLB (Hons), LLM, D.Phil,
GBS Venture Partners

Dr. Julian Chick, CEO
Avexa Limited

Peter Chapman Cook, CEO & Managing Director,
Biota

Dr. Kenneth P. Taylor, O.D., Managing Director and CEO,
Advanced OcularSystems Limited

Dr. Anna Lavelle, CEO,
AusBiotech Ltd

Dr. Stephen Carter, Managing Director & CEO,
Solbec Pharmaceuticals

Dr. Stewart James Washer, Executive Director and CEO,
Phylogica

Dr. Roland Scollay, CEO & Managing Director,
Metabolic Pharmaceuticals

Al Sokol, Partner,
Edwards Angell Palmer & Dodge LLP